New Stanford research shows alarming trends in teens' use of a popular vaping device, suggesting they need better education about its addictive potential.
A new Stanford strategy for kidney transplant wait-list management has been shown to help patients get into surgery faster.
Stanford researchers are using specially equipped mouth guards to measure how concussion happens during head impacts in high school football players.
Stanford researchers have identified a small molecule that may help curb some of the symptoms of a genetic deficiency in glucose-6-phosphate dehydrogenase.
Stanford engineer Ellen Kuhl is using computer modeling to provide insight into the progress of neurodegenerative diseases like Alzheimer's.
Scientists use a tweaked version of CRISPR gene editing to turn skin cells into neurons, and simultaneously identify neuron-specific genes.
A new variation of gene-editing technology CRISPR allows scientists to reorganize DNA in a cell's nucleus in three dimensions, altering cell function.
A network of doctors that aims to diagnose mystery diseases has named 31 newly identified conditions and diagnosed more than 100 previously unsolved cases.
A new paper outlines strategies to promote gender diversity in research teams, which can also generate new questions, techniques and results.
Digital medicine advances prompt call for more study about potential implications and ethical issues for patients and clinicians.
Cancerous tumors cause disease in two ways: they grow and spread. But a new immune therapy approach may be able to target both problems simultaneously.
Stanford scientists have found that viral infections shaped human genome evolution after interbreeding with Neanderthals 50,000 years ago.
A late-night phone call informed a Stanford doctor that his father was named a chemistry laureate for work that helped others create drugs from antibodies.
Carolyn Bertozzi, the co-director of Stanford's interdisciplinary program ChEM-H, reflects here on the program and her goals for the future.
'Mitotic catastrophe' hampers the ability of aged muscle stem cells to repair damage. Manipulating this process could lead to new therapies for old muscle.
Your trillions-strong ecosystem of gut microbes, in addition to its many other responsibilities, operates as a homespun pharmaceutical factory.